Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

58 trials

NCT05864170
Recruiting
the Safety and Efficacy Evaluation of HGI-001 Injection in Patients With Transfusion-Dependent β-Thalassemia
Early phase 1 · China · 1 site
Registry update: 29 Nov 2024
NCT05426252
Recruiting
Thal-Fabs: Reduced Toxicity Conditioning for High Risk Thalassemia
Phase 1/2 · Canada · 1 site
Registry update: 19 Dec 2023
NCT06213402
Recruiting
RADeep Multicenter European Epidemiological Platform for Patients Diagnosed With Rare Anemia Disorders (RADs)
Not applicable · Spain · 1 site
Registry update: 19 Jan 2024
NCT04099966
Recruiting
AlloSCT for Malignant and Non-malignant Hematologic Diseases Utilizing Alpha/Beta T Cell and CD19+ B Cell Depletion
Phase 2 · United States · 1 site
Registry update: 23 Oct 2026
NCT04416178
Recruiting
Sickle Cell Disease and the Genomic and Gene Therapy Needs of Stakeholders
Not applicable · United States · 1 site
Registry update: 1 May 2026
NCT05745532
Recruiting
Safety and Efficacy Evaluation of β-globin Restored Autologous Hematopoietic Stem Cells in β-thalassemia Major Patients
Early phase 1 · China · 1 site
Registry update: 29 Nov 2024
NCT07206095
Recruiting
Integrative Diagnosis for SCD and Other RADs
Not applicable · Spain · 4 sites
Registry update: 10 Nov 2026
NCT04398628
Recruiting
ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
Not applicable · United States · 76 sites
Registry update: 17 Aug 2026
NCT04528355
Recruiting
Data Collection Study of Patients With Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT With RIC
Not applicable · United States · 1 site
Registry update: 13 Jan 2026
NCT04143724
Recruiting
Study of Safety & PK of Luspatercept (ACE-536) in Pediatric Participants With Beta (β)-Thalassemia
Phase 2 · China, Germany, Greece, India, Italy, Lebanon, Thailand, United States · 26 sites
Registry update: 10 Jul 2026
NCT04008368
Recruiting
Repeat Peripheral Blood Stem Cell Transplantation for Patients With Sickle Cell Disease and Falling Donor Myeloid Chimerism Levels
Phase 1/2 · United States · 1 site
Registry update: 26 Oct 2026
NCT03937817
Recruiting
Collection of Human Biospecimens for Basic and Clinical Research Into Globin Variants
Not applicable · United States · 1 site
Registry update: 2 Oct 2026
NCT04064060
Recruiting
A Study to Evaluate Long-term Safety in Participants Who Have Participated in Other Luspatercept (ACE-536) Clinical Trials
Phase 3 · Australia, Belgium, Bulgaria, Canada, China, Germany, Spain, France, United Kingdom, Greece, Israel, Italy, Japan, Lebanon, Malaysia, Netherlands, Sweden, Thailand, Tunisia, Taiwan, United States · 143 sites
Registry update: 1 Jul 2026
NCT03653338
Recruiting
T-Cell Depleted Alternative Donor Bone Marrow Transplant for Sickle Cell Disease (SCD) and Other Anemias
Phase 1/2 · United States · 1 site
Registry update: 13 Aug 2026
NCT02675959
Recruiting
Myeloablative Conditioning, Prophylactic Defibrotide and Haplo AlloSCT for Patients With Sickle Cell Disease
Phase 2 · United States · 4 sites
Registry update: 27 Jul 2026
NCT04872179
Recruiting
International Registry of Patients With Alpha Thalassemia
Not applicable · United States · 1 site
Registry update: 2 Sept 2026
NCT01962415
Recruiting
Reduced Intensity Conditioning for Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT
Phase 2 · United States · 1 site
Registry update: 15 Dec 2025
NCT01245179
Recruiting
Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease
Phase 1 · United States · 1 site
Registry update: 9 Jan 2026

Ordered by registry start date. Freshness and sponsorship never change the order.